Identification and optimization of small molecules that restore E-cadherin expression and reduce invasion in colorectal carcinoma cells.
about
Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancerA high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptorPerspectives on the discovery of small-molecule modulators for epigenetic processes.High-throughput screening strategies for targeted identification of therapeutic compounds in colorectal cancer.Total synthesis and biological evaluation of phidianidines A and B uncovers unique pharmacological profiles at CNS targets.Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transitionMicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer.Natural history of hepatic metastases from colorectal cancer--pathobiological pathways with clinical significance.ML327 induces apoptosis and sensitizes Ewing sarcoma cells to TNF-related apoptosis-inducing ligand.The development of high-content screening (HCS) technology and its importance to drug discovery.SERPINI1 regulates epithelial-mesenchymal transition in an orthotopic implantation model of colorectal cancer.Optimization of a small molecule probe that restores e-cadherin expression.Total Synthesis (+)-7-Bromotrypargine and Unnatural Analogs: Biological Evaluation Uncovers Activity at CNS Targets of Therapeutic Relevance.Reduced E-Cadherin expression is a prognostic biomarker of non-small cell lung cancer: a meta-analysis based on 2395 subjectscFLIP critically modulates apoptotic resistance in epithelial-to-mesenchymal transition.Isoxazole compound ML327 blocks MYC expression and tumor formation in neuroblastoma.
P2860
Q26829478-F5C057DE-8AD6-4D54-A937-B68548DA7A64Q28828478-9B38E96F-FBED-4058-BC4B-B7F7CEB9A172Q34185471-636A5F81-66C8-4314-A234-40AE57ECDD5BQ36184195-868F743E-97B1-43DF-8CBE-435B52D4A8D6Q36248536-D13CAC34-4F98-4386-A4F9-E840DFBC0B1FQ36356117-80A65788-8058-4AF9-8B41-ADF1C9C48493Q37162405-1264B893-16B4-4040-9184-D564ED8936A6Q38205428-4956CDE2-A5BC-4FA4-9F3E-14FEAB6EBF82Q38697040-A5CC0BFA-F839-4F1F-B56D-B5685231DCAAQ38772165-AB1352B0-BDDE-4B70-B807-92F7A7CD041BQ38792830-2639012D-630B-40D5-9A81-75863072D33AQ38841578-6DC2C5A7-DD0E-4D53-B9BA-3F2C710B8D9AQ40256255-0367C884-E696-4A16-896A-073F5B65F658Q41637140-78283941-D198-4B6C-8446-3AEDE52A4438Q47103256-C5AE2629-2FA3-47F4-BC54-41D4FE735216Q47112132-5AEFB55A-F9BC-4CEB-A691-CB68277A6DFF
P2860
Identification and optimization of small molecules that restore E-cadherin expression and reduce invasion in colorectal carcinoma cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Identification and optimizatio ...... in colorectal carcinoma cells.
@en
Identification and optimizatio ...... in colorectal carcinoma cells.
@nl
type
label
Identification and optimizatio ...... in colorectal carcinoma cells.
@en
Identification and optimizatio ...... in colorectal carcinoma cells.
@nl
prefLabel
Identification and optimizatio ...... in colorectal carcinoma cells.
@en
Identification and optimizatio ...... in colorectal carcinoma cells.
@nl
P2093
P2860
P356
P1433
P1476
Identification and optimizatio ...... in colorectal carcinoma cells
@en
P2093
A Scott Pearson
Alex G Waterson
C David Weaver
Chris Farmer
Connie Weaver
Emily Days
Suzanne Brady
Sydney L Stoops
P2860
P304
P356
10.1021/CB100305H
P577
2011-02-09T00:00:00Z